Mats Christer Henriksson

Fresenius Kabi Austria GmbH develops and distributes IV drugs and nutrition products. It specializes in infusion and nutrition therapy. The firm offers active pharmaceutical ingredients, infusion therapy, oncology drugs, parenteral nutrition, enteral nutrition, medical devices, and hesylation. The company was founded in 1997 and is headquartered in Graz, Austria.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi Japan KK is a leading Japanese company for infusion therapy, nutrition therapy, and blood transfusion technology products. The private company is based in Tokyo, Japan. The company provides drugs and medical equipment to patients with severe chronic diseases, which are indispensable in acute care and used to treat patients at the hospital and home.

Labesfal-Laboratórios Almiro SA is a pharmaceutical company based in Santiago de Besteiros, Portugal. Part of Fresenius SE & Co. KGaA, the Portuguese company develops, produces, and markets medical drugs and devices for therapy and the care of critical and chronic patients worldwide. The private company's product portfolio includes diabetes mellitus, critical disease, fluidotherapy, hepatic insufficiency, renal insufficiency, maldigestion/malabsorption, oncology, pediatrics, replacement nutritional support, medical devices, disposable devices, drainage manipulation technology, infusion technology, nutrition, enteric nutritional supplements, parenteral nutrition, specific amino acids, lipid emulsions, volume replacement, colloids, irrigation solutions, transfusion technology, and more. The company is committed to ethics, responsibility, compliance, diversity, integrity, safety, and social responsibility. The company also prioritizes career development and employee well-being.

Fresenius Kabi Italia Srl specializes in drugs and technologies for infusion, transfusion and clinical nutrition. The firm’s products include autologous, colloids, biosimilars, enteral nutrition, and infusion therapy. The company is headquartered in Isola della Scala, Italy.

Part of Fresenius SE & Co. KGaA, Beijing Fresenius Kabi Pharmaceutical Co. Ltd. is a private company that manufactures infusion solutions for volume therapy and standard infusion solutions. Beijing Fresenius Kabi Pharmaceutical Co. Ltd. is based in Beijing, China. Beijing Fresenius Kabi Pharmaceutical Co. was acquired by Fresenius Kabi AG on April 05, 2005 for $30.21 million.

Fenwal, Inc. is a global medical technology company focused on improving transfusion medicine through expertise in blood separation, collection, filtration, storage, and transfusion. It offers apheresis collections, manual collections, therapeutics, specialty products, platelet safety, data management, data management, and customer solutions The company was founded in 1949 and is headquartered in Lake Zurich, IL.

Founded in 1966, FHC (Holdings) Ltd. is a British company that functions as an investment holding company. Part of Fresenius SE & Co. KGaA, the private company is based in Runcorn, UK.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi Pharmaceuticals Holding, Inc. is a pharmaceutical company based in Wilmington, DE. The private company develops pharmaceutical products.

Part of Fresenius SE & Co. KGaA, Fresenius Kabi (Singapore) Pte Ltd. is a Singaporean healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition. The private company is based in Singapore, Singapore. Fresenius Kabi's corporate philosophy is "caring for life," and they offer information about their business fields and career opportunities on their website.